A 4-year old girl presenting gait difficulty was referred for spine X-ray and Magnetic Resonance Imaging (MRI). MRI showed several diffuse hypointense signals in sacral and lumbar vertebrae. In order to exclude a possible lymphoproliferative disease a 18-fluorodeoxyglucose positron emission tomography/computed tomography ( 18 F-FDG-PET/CT) was requested. The PET/CT scan confirmed the MRI findings and demonstrated additional findings in the sternum. Therefore, a bone marrow biopsy was performed and a diagnosis of acute lymphoblastic leukaemia -early B type was made.
Background
Acute lymphoblastic leukemia (ALL) is the most common malignant neoplasm in childhood [1] . The common sites of primary involvement or recurrence are the testicles (2%), central nervous system (CNS) (5-11%), ovaries, breast, eye, skin, and lymph nodes [1] [2] [3] . There are limited data in literature regarding ALL with bone as primary involvement in pediatric patients, assessed by 18 F-FDG PET/CT [4] .
MRI is usually performed in selected districts in patients with ALL on the basis of the clinical suspicion [5] ; PET/CT is not routinely used. We aim to show the clinical utility of 18 F-FDG PET/CT in detecting extra-haematological sites of disease in a patient with diffuse bone involvement as initial manifestation of ALL.
Case report
In October 2012, after an accidental fall, the 4-year old girl presented difficulty in walking. A month later, the girl fell again and presented fever, which was treated with paracetamol. Difficulty in walking was still present, without apparent pain or any other symptoms.
In January 2013, an X-ray of the inferior limbs was negative ( Figure 1) . Thus, the girl received a neuropsychiatric evaluation, which ruled out any possible neurologic disease.
Then the paediatrician requested a blood sample examination, which showed an increase of the inflammation markers: VES 83 mm/h (v.n. < 29), PCR 146.7 mg/L (< 10); white blood cells were within the normal range (5.8 × 10 3 /uL). As a consequence, a suspicion of multifocal chronic osteomyelitis of the lower limbs rose. In consideration of the blood test results, a thoracic X-ray was performed and demonstrated a basal parenchymal consolidation in the left lung. Therefore, the girl was transferred to the Department of Infectious Diseases. During the hospitalization, the patient received an empiric antibiotic therapy (Ceftriaxone, Amoxicillina e Clavulanic Acid) with resolution of the pulmonary finding.
In the following days, due to the onset of low back pain, the girl underwent a MRI of the brain and spine, which showed several diffuse hypointensity within the bone marrow, in sacral and lumbar metamera, and a hiperintensity signal in S1 in the T2-weighted 
Clinical vignette
Discussion ALL is a serious haematological disease affecting mainly pediatric patients. Primary involvement or recurrence of ALL can occur in the testicles (2%) [1] and the central nervous system (CNS) (5-11%) [2] . Other possible sites of disease include ovaries, breast, eye, skin, and lymph nodes [3] . To the best of our knowledge, there is limited lack of reports regarding ALL with bone involvement as primary involvement in pediatric patients, valuated by 18 F-FDG PET/CT [4] .
This case shows the usefulness of 18 F-FDG PET/CT, as full-body imaging exams, in detecting extra-haematological sites of disease in a patient with diffuse bone involvement as initial manifestation of ALL. In our case, 18 F-FDG-PET/CT was helpful in detecting an additional lesion (in the sternum) and in suggesting the presence of a lymphoproliferative disease, subsequently confirmed by the bone marrow biopsy. MRI is usually performed only in selected districts on the basis of the clinical suspicion [5] . It follows that sites of disease beyond the field of view may be missed. In our patient PET/CT was able to reveal the pathological bone involvement and played a crucial role in the clinical management, suggesting the need of a bone marrow examination and yielding a prompt initiation of the chemotherapy.
Nowadays PET/CT is gaining increasing importance in the diagnostic work-up of several diseases in pediatric patients [6] [7] [8] , but is not routinely used in ALL yet. The role of PET/CT in pediatric patients needs to be further evaluated, considering the effective dose, ranging from 7.3 to 9.3 mSv, provided by using a standard PET/CT protocol (tube voltage, 120 kVp; tube current, 80 mAs; and abdominal pitch, 1.5:1) [9] .
Potential dose reduction and additional diagnostic benefit could be reached in the assessment of possible multifocal bone marrow involvement by combining PET and MRI data in a whole-body examination by introducing hybrid PET/MRI in the evaluation of pediatric patients with ALL [9, 10] .
